Full Breakdown
Federal Withdrawal Leaves Minors Exposed to Indoor Tanning
5/6/2026, 11:31:31 PM
Federal Withdrawal of Minor Indoor Tanning Ban
On March 16, 2026, Health and Human Services Secretary Robert F. Kennedy Jr. announced the withdrawal of a long-standing FDA proposal that would have prohibited anyone under 18 from using indoor tanning devices. The draft rule also required users to sign a form acknowledging cancer and skin-aging risks.
Background & Context: State Bans and Sun-Exposure Advocacy
The proposal, first introduced in 2015, drew over 9,000 comments from physicians, cancer researchers, and industry. Nineteen states and D.C. already ban minors; about two dozen jurisdictions require parental permission. Kennedy’s “Make America Healthy Again” platform promotes regular sun exposure and discourages sunscreen.
Data & Statistics: UV Exposure and Cancer Risk
UVA output in tanning beds is ~15 times natural levels; a session’s UVB equals noon equatorial sunlight, and use before age 35 raises melanoma risk by 75 %. Melanoma diagnoses have risen 46 % in the past decade, and WHO classifies tanning beds as a Group 1 carcinogen.
Official Statements & Responses: Agency Rationale and State Patchwork
In his withdrawal letter, Kennedy said the agency is pulling the rule to reconsider the best means of addressing the issue after reviewing scientific and technical comments. The Department of Health and Human Services declined further comment. Meanwhile, state health departments continue to enforce a patchwork of age-related restrictions.
Criticism & Opposition: Dermatology Community Reacts
Dermatologists expressed disappointment, warning that early-life UV exposure drives lifelong cancer risk. Dr. Clara Curiel-Lewandrowski highlighted inconsistent state guardrails and questioned reliance on a system she deems ineffective. The Skin Cancer Foundation’s president, Dr. Deborah S. Sarnoff, said the withdrawal undermines cancer-prevention efforts and pledged continued advocacy for a nationwide ban.
Conflicting Reports & Gaps: Unclear Scientific Basis
The FDA did not disclose which scientific studies or unintended consequences prompted the withdrawal, nor how it will address the documented rise in melanoma and the WHO carcinogen classification.
Verbatim Quotes
- “In light of the scientific and technical concerns raised in the comments on the Proposed Rule, concerns regarding possible unintended consequences of certain proposals in the Proposed Rule, and potential alternatives proposed in comments received on the Proposed Rule, FDA is withdrawing the Proposed Rule in order to reconsider the best means for addressing the issues,” — Robert F. Kennedy Jr., Secretary of Health and Human Services
- “They’re really blasting you with these super physiological doses of UV radiation that you couldn’t even find in a natural environment,” — Hunter Shain, Associate Professor of Dermatology, UC San Francisco
- “As you can see, when it’s left to the states, the implementation and the guardrails to minimize the exposure to carcinogens are not consistent. ... Why are you going to default to a system that we know isn’t working correctly?” — Dr. Clara Curiel-Lewandrowski, Chair of Dermatology, University of Arizona
- “On the positive side, we made the public very aware of this issue, and this fight is far from over. We won’t be satisfied until tanning beds are banned in this country.” — Dr. Deborah S. Sarnoff, President, Skin Cancer Foundation
What’s Next
The FDA has not provided further details on future regulatory actions. Dermatology societies and the Skin Cancer Foundation say they will continue public-education campaigns and lobbying for uniform federal standards, while states may consider new restrictions.
